|
G |
Acan |
aggrecan |
increases expression |
ISO |
alginic acid results in increased expression of ACAN mRNA |
CTD |
PMID:16371897 |
|
NCBI chr 1:140,762,758...140,824,441
Ensembl chr 1:140,762,758...140,824,441
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
increases expression |
ISO |
alginic acid results in increased expression of COL10A1 mRNA |
CTD |
PMID:16371897 |
|
NCBI chr20:41,180,295...41,190,664
Ensembl chr20:41,184,287...41,189,633
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
alginic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:12723939 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
alginic acid inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; alginic acid inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; alginic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:12723939 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Gusb |
glucuronidase, beta |
increases secretion |
EXP |
p-Methoxy-N-methylphenethylamine results in increased secretion of GUSB protein |
CTD |
PMID:9545557 |
|
NCBI chr12:30,202,066...30,215,583
Ensembl chr12:30,198,822...30,227,771
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases activity |
EXP |
p-Methoxy-N-methylphenethylamine results in increased activity of HTR1A protein |
CTD |
PMID:16415902 |
|
NCBI chr 2:36,246,628...36,247,896
Ensembl chr 2:36,246,628...36,247,896
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
affects response to substance |
ISO |
KIT protein affects the susceptibility to p-Methoxy-N-methylphenethylamine |
CTD |
PMID:32871113 |
|
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
|
|
G |
Kng2 |
kininogen 2 |
decreases activity |
ISO |
p-Methoxy-N-methylphenethylamine results in decreased activity of KNG1 protein |
CTD |
PMID:1371395 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
multiple interactions increases activity |
EXP |
atractylon inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased activity of LCK protein]; damnacanthal inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased activity of LCK protein]; pyeongwee-san extract inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased activity of LCK protein] |
CTD |
PMID:27553716 |
|
NCBI chr 5:147,750,976...147,779,627
Ensembl chr 5:147,750,973...147,761,983
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
epigallocatechin gallate inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:29402411 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
epigallocatechin gallate inhibits the reaction [p-Methoxy-N-methylphenethylamine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:29402411 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mrgprx2 |
MAS related GPR family member X2 |
affects response to substance |
ISO |
MRGPRX2 protein affects the susceptibility to p-Methoxy-N-methylphenethylamine |
CTD |
PMID:32871113 |
|
NCBI chr 1:103,743,746...103,760,945
Ensembl chr 1:103,741,503...103,760,913
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases activity |
ISO |
p-Methoxy-N-methylphenethylamine results in decreased activity of NR3C1 protein |
CTD |
PMID:7887964 |
|
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases secretion multiple interactions |
EXP |
Poloxamer results in decreased secretion of ADIPOQ protein carvacrol inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]; carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]]; Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein] |
CTD |
PMID:29071762 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
Poloxamer results in increased expression of CASP3 protein carvacrol inhibits the reaction [Poloxamer results in increased expression of CASP3 protein]; carvacrol inhibits the reaction [Simvastatin promotes the reaction [Poloxamer results in increased expression of CASP3 protein]]; Simvastatin promotes the reaction [Poloxamer results in increased expression of CASP3 protein] |
CTD |
PMID:29071762 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP |
carvacrol inhibits the reaction [Poloxamer results in decreased activity of CAT protein]; carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased activity of CAT protein]]; Simvastatin inhibits the reaction [Poloxamer results in decreased activity of CAT protein] |
CTD |
PMID:29071762 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions increases secretion |
EXP |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of CKM protein] |
CTD |
PMID:29071762 |
|
NCBI chr 1:80,321,507...80,331,841
Ensembl chr 1:80,321,585...80,331,841
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CSF1R mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor subunit alpha |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CSF2RA mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr14:1,462,292...1,467,264
Ensembl chr14:1,462,358...1,467,264
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[nickel monoxide co-treated with Poloxamer] results in increased expression of HMOX1 mRNA |
CTD |
PMID:25964212 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of ICAM1 mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of ICAM2 mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr10:94,569,889...94,581,218
Ensembl chr10:94,569,890...94,576,512
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of IL1B mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of IL6 mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of ITGAM mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
|
|
G |
Lep |
leptin |
multiple interactions increases secretion |
EXP |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of LEP protein]; Simvastatin inhibits the reaction [Poloxamer results in increased secretion of LEP protein] |
CTD |
PMID:29071762 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Mb |
myoglobin |
multiple interactions increases secretion |
EXP |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of MB protein]; Simvastatin inhibits the reaction [Poloxamer results in increased secretion of MB protein] |
CTD |
PMID:29071762 |
|
NCBI chr 7:118,101,633...118,108,864
Ensembl chr 7:118,101,634...118,108,864
|
|
G |
Pnlip |
pancreatic lipase |
decreases activity |
ISO |
Poloxamer results in decreased activity of PNLIP protein |
CTD |
PMID:16872557 |
|
NCBI chr 1:279,798,187...279,811,372
Ensembl chr 1:279,798,187...279,811,372
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [Nanotubes, Carbon inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein]] |
CTD |
PMID:17709331 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of TNF mRNA] |
CTD |
PMID:32169474 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
|
|